Simpson D Books
POOLED ANALYSIS OF SAFETY DATA FROM MONOTHERAPY STUDIES OF THE BRUTON TYROSINE KINASE (BTK) INHIBITOR, ZANUBRUTINIB (BGB-3111), IN B-CELL MALIGNANCIES
By Roberts A. W, Simpson D, Song Y., Gottlieb, D., Yang H., Li, J., Tam, C. S., Opat, S., Zhu, J., Cull, G., Marlton, P., Qiu, L., Seymour, J. F., Du, C., Feng, S., Ji, M., Lin, L., Novotny, W., Wang, A., Trotman, J.
Read More
FIVE-YEAR FOLLOW-UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
By Simpson D, Owen C, Li, J., Ghia, P., Offner, F., Tedeschi, A., Burger, J., Barr, P. M., Robak, T., Bairey, O., Hillmen, P., Coutre, S., Devereux, S., Grosicki, S., McCarthy, H., Moreno, C., Dai, S., Lal, I., Dean, J. P., Kipps, T. J.
Read More
